(CNN/FUTURO 360) – The US Food and Drug Administration (FDA) wants to simplify the process of the vaccine against COVID-19 to make it more like what happens with the flu shot, according to documents posted online Monday. That means simplifying vaccine composition, immunization schedules, and regular updates on coronavirus vaccines.
The FDA said it expects to test circulating strains of the virus that causes COVID-19 at least annually and decide by June which strains to select for the fall season, as well as the process for updating flu vaccines.
In the future, the agency said, most people may need only one dose of a COVID-19 vaccine to restore protectionregardless of how many doses of the vaccine they have already received. Two doses may be needed for very young people who have not been exposed, or for older or immunocompromised people, according to the FDA’s information document for its vaccine advisers.
This simplification of vaccine composition should reduce complexity, decrease vaccine administration errors due to the complexity of the number of different vial presentations, and potentially increase vaccine compliance by allowing clearer communication,” he said. the fda.
The FDA’s plan was first reported on National Public Radio, NPR.
The agency’s independent vaccine advisers, the Vaccines and Related Biologicals Advisory Committee, met Thursday to discuss the future of COVID-19 vaccine regimens.
Several members of the committee expressed their concern regarding defining an annual vaccination schedule because some things about COVID-19 are still unknown.
Experts stressed that COVID-19 it was not a common flu due to its behavior and the ability to mutate into new variants.
as slogan TelemundoDr. Eric Rubin, managing editor of the New Enganld Journal of Medicine, noted that “it is difficult to say at this point that (the vaccine) will become an annual thing.”
